SCHEMBL2369918

SCHEMBL2369918

c1cnc(NC2CC2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.42
ALDH1A1 P00352 7/20 0.41
KDM4E B2RXH2 6/20 0.41
MALT1 Q9UDY8 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
AOC1 P19801 1/20 0.39
SYK P43405 1/20 0.38
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
ROCK2 O75116 1/20 0.37
ROCK1 Q13464 1/20 0.37
USP2 O75604 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22877113 0.92 KDM4E (0.50) HCAR3ALDH1A1KDM4EL3MBTL1MEN1
SCHEMBL5847287 0.92 KDM4E (0.46) HCAR3ALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL31057008 0.91 SYK (0.47) HCAR3SYKROCK2ROCK1
SCHEMBL26814095 0.91 SYK (0.47) HCAR3SYKROCK2ROCK1
SCHEMBL9901706 0.90 KDM4E (0.53) HCAR3ALDH1A1KDM4EL3MBTL1MEN1
SCHEMBL30183229 0.90 KDM4E (0.53) HCAR3ALDH1A1KDM4EL3MBTL1MEN1
SCHEMBL30182919 0.90 KDM4E (0.53) HCAR3ALDH1A1KDM4EL3MBTL1MEN1
SCHEMBL13326729 0.87 HRH3 (0.51) ALDH1A1MEN1KMT2AROCK2ROCK1
SCHEMBL28179313 0.86 GBA1 (0.43) ALDH1A1KDM4EL3MBTL1
SCHEMBL28179312 0.86 GBA1 (0.43) ALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023017937-A1 NOVEL INHIBITOR FOR MULTIPLE PROTEIN KINASES 계명대학교 산학협력단 2023-02-16 WO disclosed
CN-105960404-B The inhibitor of bruton's tyrosine kinase 药品循环有限责任公司 2019-09-03 CN disclosed
EP-2545042-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-01-16 EP disclosed
WO-2011112191-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2011-09-15 WO disclosed